Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    IRLAB Therapeutics

    MCap

    SEK653m

    Last close

    SEK14.10

    ▲ 1.50 (11.90%)

    VolitionRx

    MCap

    USD51m

    Last close

    USD0.60

    ▲ 0.05 (9.82%)

    Portobello SpA

    MCap

    EUR12m

    Last close

    EUR2.38

    ▲ 0.20 (9.17%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Executive interview – Nanoco Group

Executive interview – Nanoco Group

Nanoco Group — 9 videos in collection

More on this equity

CEO of Nanoco, Dr Michael Edelman, discusses the operational highlights of the last year, which included the first commercial orders for the company’s cadmium free quantum dots in computer displays. He explains why the commercialisation cycle has been more protracted than initially thought but expresses confidence that the company now has a healthy pipeline of potential customers moving closer towards commercial orders. Michael also provides an update on the company’s competitive positioning, and the developments of the technology for non-display applications. Finally, Michael talks about the milestones that investors should be looking for in 2018.

< Previous
Next >

You may also be interested in these:

TMT

Nanoco – executive interview

TMT

Nanoco Group - executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free